Cargando…
Fatal heart disease among cancer patients
As the overlap between heart disease and cancer patients increases as cancer-specific mortality is decreasing and the surviving population is aging, it is necessary to identify cancer patients who are at an increased risk of death from heart disease. The purpose of this study is to identify cancer p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181822/ https://www.ncbi.nlm.nih.gov/pubmed/32332714 http://dx.doi.org/10.1038/s41467-020-15639-5 |
_version_ | 1783526126363082752 |
---|---|
author | Stoltzfus, Kelsey C. Zhang, Ying Sturgeon, Kathleen Sinoway, Lawrence I. Trifiletti, Daniel M. Chinchilli, Vernon M. Zaorsky, Nicholas G. |
author_facet | Stoltzfus, Kelsey C. Zhang, Ying Sturgeon, Kathleen Sinoway, Lawrence I. Trifiletti, Daniel M. Chinchilli, Vernon M. Zaorsky, Nicholas G. |
author_sort | Stoltzfus, Kelsey C. |
collection | PubMed |
description | As the overlap between heart disease and cancer patients increases as cancer-specific mortality is decreasing and the surviving population is aging, it is necessary to identify cancer patients who are at an increased risk of death from heart disease. The purpose of this study is to identify cancer patients at highest risk of fatal heart disease compared to the general population and other cancer patients at risk of death during the study time period. Here we report that 394,849 of the 7,529,481 cancer patients studied died of heart disease. The heart disease-specific mortality rate is 10.61/10,000-person years, and the standardized mortality ratio (SMR) of fatal heart disease is 2.24 (95% CI: 2.23–2.25). Compared to other cancer patients, patients who are older, male, African American, and unmarried are at a greatest risk of fatal heart disease. For almost all cancer survivors, the risk of fatal heart disease increases with time. |
format | Online Article Text |
id | pubmed-7181822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-71818222020-04-29 Fatal heart disease among cancer patients Stoltzfus, Kelsey C. Zhang, Ying Sturgeon, Kathleen Sinoway, Lawrence I. Trifiletti, Daniel M. Chinchilli, Vernon M. Zaorsky, Nicholas G. Nat Commun Article As the overlap between heart disease and cancer patients increases as cancer-specific mortality is decreasing and the surviving population is aging, it is necessary to identify cancer patients who are at an increased risk of death from heart disease. The purpose of this study is to identify cancer patients at highest risk of fatal heart disease compared to the general population and other cancer patients at risk of death during the study time period. Here we report that 394,849 of the 7,529,481 cancer patients studied died of heart disease. The heart disease-specific mortality rate is 10.61/10,000-person years, and the standardized mortality ratio (SMR) of fatal heart disease is 2.24 (95% CI: 2.23–2.25). Compared to other cancer patients, patients who are older, male, African American, and unmarried are at a greatest risk of fatal heart disease. For almost all cancer survivors, the risk of fatal heart disease increases with time. Nature Publishing Group UK 2020-04-24 /pmc/articles/PMC7181822/ /pubmed/32332714 http://dx.doi.org/10.1038/s41467-020-15639-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Stoltzfus, Kelsey C. Zhang, Ying Sturgeon, Kathleen Sinoway, Lawrence I. Trifiletti, Daniel M. Chinchilli, Vernon M. Zaorsky, Nicholas G. Fatal heart disease among cancer patients |
title | Fatal heart disease among cancer patients |
title_full | Fatal heart disease among cancer patients |
title_fullStr | Fatal heart disease among cancer patients |
title_full_unstemmed | Fatal heart disease among cancer patients |
title_short | Fatal heart disease among cancer patients |
title_sort | fatal heart disease among cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181822/ https://www.ncbi.nlm.nih.gov/pubmed/32332714 http://dx.doi.org/10.1038/s41467-020-15639-5 |
work_keys_str_mv | AT stoltzfuskelseyc fatalheartdiseaseamongcancerpatients AT zhangying fatalheartdiseaseamongcancerpatients AT sturgeonkathleen fatalheartdiseaseamongcancerpatients AT sinowaylawrencei fatalheartdiseaseamongcancerpatients AT trifilettidanielm fatalheartdiseaseamongcancerpatients AT chinchillivernonm fatalheartdiseaseamongcancerpatients AT zaorskynicholasg fatalheartdiseaseamongcancerpatients |